Should we stop reporting hyperkeratosis (HK) on cervicovaginal (CV) smears as we adopt the 2001 Bethesda System

被引：0

作者：

Nayar, R ^{[1
]}

Williamson, BA ^{[1
]}

Gunn, R ^{[1
]}

Tarjan, G ^{[1
]}

De Frias, DVS ^{[1
]}

机构：

[1] Northwestern Univ, Sch Med, Chicago, IL USA

来源：

LABORATORY INVESTIGATION | 2002年 / 82卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

330

引用

页码：81A / 82A

页数：2

共 12 条

[1] Should we stop reporting hyperkeratosis (HK) on cervicovaginal (CV) smears as we adopt the 2001 Bethesda system
Nayar, R
Williamson, B
Gunn, R
Tarjan, G
De Frias, DVS
MODERN PATHOLOGY, 2002, 15 (01) : 81A - 82A
[2] Impact of the new Bethesda System 2001 on specimen adequacy of conventional cervicovaginal smears
Fidda, N
Miron, J
Rodgers, WH
Rader, A
DIAGNOSTIC CYTOPATHOLOGY, 2004, 30 (04) : 235 - 239
[3] The impact of the new Bethesda system 2001 on specimen adequacy of conventional cervicovaginal smears.
Fidda, N
Miron, J
Rader, A
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 617 - 617
[4] Should we all adopt the Dietary Approach to Stop Hypertension (DASH) diet?
Lysne, Vegard
Anfinsen, Aslaug Matre
Van Parys, Anthea
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (07) : 1112 - 1113
[5] INTERINSTITUTIONAL COMPARISON OF BETHESDA SYSTEM REPORTING - Q-PROBES EVALUATION OF CERVICOVAGINAL (CV) SPECIMEN ADEQUACY
HEARD, NV
ZARBO, RJ
LABORATORY INVESTIGATION, 1993, 68 (01) : A30 - A30
[6] THE CANADIAN-HEALTH-CARE-SYSTEM - SHOULD WE ADOPT IT
CODY, DTR
AMERICAN JOURNAL OF OTOLOGY, 1994, 15 (01): : 4 - 7
[7] Predictive value of the Bethesda System Reporting for Thyroid Cytopathology (BSRTC): Should we keep categories III and IV?
Silva, R.
Barroca, H.
Amendoeira, I.
Eloy, C.
VIRCHOWS ARCHIV, 2013, 463 (02) : 155 - 155
[8] Q: Is there an age at which we should stop performing screening Pap smears and mammography.?
Harris, P
Carnes, M
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2002, 69 (04) : 272 - 273
[9] The Role of Journals in Reporting Sex and Gender-Based Outcomes: Should We Adopt Guidelines, and What Else Can We Do to Improve Reporting?
Schoenfeld, Andrew J.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2024, 106 (17): : 1610 - 1614
[10] Adverse effects during treatment with renin-angiotensin-aldosterone system inhibitors; should we stay or should we stop?
Leon, Silvia J.
Carrero, Juan Jesus
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2023, 32 (03): : 290 - 296

← 1 2 →